Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond G Booth

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
ACS Chemical Neuroscience|May 27, 2015
An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse ModelsClinton E Canal, Daniel E Felsing, Yue Liu, et al.
ACS Chemical Neuroscience|July 31, 2015
Correction to an orally active phenylaminotetralin-chemotype serotonin 5-HT7 and 5-HT1A receptor partial agonist that corrects motor stereotypy in mouse modelsClinton E Canal, Daniel E Felsing, Yue Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 26, 2004
Domain swapping in the human histamine H1 receptorRemko A Bakker, Guido Dees, Juan J Carrillo, et al.
Pharmacology Research & Perspectives|October 14, 2023
Effects of (-)-MBP, a novel 5-HT<sub>2C</sub> agonist and 5-HT<sub>2A/2B</sub> antagonist/inverse agonist on brain activity: A phMRI study on awake micePreeti K Sathe, Gargi R Ramdasi, Kaylie Giammatteo, et al.
Bioorganic & Medicinal Chemistry|December 29, 2019
Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> G protein-coupled receptor affinity, 3D-QSAR and molecular modelingCharles K Perry, Austen B Casey, Daniel E Felsing, et al.
Bioorganic & Medicinal Chemistry|February 24, 2015
Novel 4-substituted-N,N-dimethyltetrahydronaphthalen-2-amines: synthesis, affinity, and in silico docking studies at serotonin 5-HT2-type and histamine H1 G protein-coupled receptorsRajeev Sakhuja, Krishnakanth Kondabolu, Tania Córdova-Sintjago, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclaseDavid M Mottola, Jason D Kilts, Mechelle M Lewis, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
ACS Chemical Neuroscience|May 27, 2015
An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse ModelsClinton E Canal, Daniel E Felsing, Yue Liu, et al.
ACS Chemical Neuroscience|July 31, 2015
Correction to an orally active phenylaminotetralin-chemotype serotonin 5-HT7 and 5-HT1A receptor partial agonist that corrects motor stereotypy in mouse modelsClinton E Canal, Daniel E Felsing, Yue Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 26, 2004
Domain swapping in the human histamine H1 receptorRemko A Bakker, Guido Dees, Juan J Carrillo, et al.
Pharmacology Research & Perspectives|October 14, 2023
Effects of (-)-MBP, a novel 5-HT<sub>2C</sub> agonist and 5-HT<sub>2A/2B</sub> antagonist/inverse agonist on brain activity: A phMRI study on awake micePreeti K Sathe, Gargi R Ramdasi, Kaylie Giammatteo, et al.
Bioorganic & Medicinal Chemistry|December 29, 2019
Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> G protein-coupled receptor affinity, 3D-QSAR and molecular modelingCharles K Perry, Austen B Casey, Daniel E Felsing, et al.
Bioorganic & Medicinal Chemistry|February 24, 2015
Novel 4-substituted-N,N-dimethyltetrahydronaphthalen-2-amines: synthesis, affinity, and in silico docking studies at serotonin 5-HT2-type and histamine H1 G protein-coupled receptorsRajeev Sakhuja, Krishnakanth Kondabolu, Tania Córdova-Sintjago, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclaseDavid M Mottola, Jason D Kilts, Mechelle M Lewis, et al.
Pageof 4